Cerebrolysin vs Dihexa
Overview
Cerebrolysin and Dihexa are both cognitive enhancement peptides, but they differ in mechanism, dosing, and regulatory status.
This page compares Cerebrolysin and Dihexa across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Cerebrolysin | Dihexa | |
|---|---|---|
| Category | Cognitive Enhancement | Cognitive Enhancement |
| Regulatory status (US) | Research use only | Compounding (Rx) — Apr 2026 |
| Typical dosage | 5-10 ml | Research protocols vary |
| Frequency | multiple times weekly | research |
| Reported benefits | Neuroprotection, stroke recovery support, cognitive improvement, neurodegenerative disease support | Powerful cognitive enhancement, potential neuroregeneration, memory improvement |
| Reported side effects | Generally well-tolerated. Possible: dizziness, agitation | Research compound. Long-term effects unknown |
Key differences
Primary use. Cerebrolysin is categorised under Cognitive Enhancement, while Dihexa falls under Cognitive Enhancement. Because they target a similar goal, they are common alternatives to weigh against each other.
Regulatory status. Cerebrolysin: not FDA-approved; treated as a research compound. Dihexa: not FDA-approved; compounding permitted with a prescription as of April 2026.
Dosing. Cerebrolysin is typically dosed at 5-10 ml (multiple times weekly). Dihexa is typically dosed at Research protocols vary (research).
Can you stack them?
Some protocols combine peptides, but stacking Cerebrolysin and Dihexa has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Cerebrolysin and Dihexa?
- Cerebrolysin and Dihexa are both cognitive enhancement peptides, but they differ in mechanism, dosing, and regulatory status. Cerebrolysin is not FDA-approved; generally classified as a research compound, whereas Dihexa is not FDA-approved; compounding permitted with a prescription (as of April 2026).
- What is Cerebrolysin used for?
- Neuroprotection, recovery.
- What is Dihexa used for?
- Potent cognitive enhancer.
- Can you take Cerebrolysin and Dihexa together?
- Some users combine peptides within a single protocol, but stacking Cerebrolysin and Dihexa has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Cerebrolysin or Dihexa FDA-approved?
- Cerebrolysin is not FDA-approved; generally classified as a research compound. Dihexa is not FDA-approved; compounding permitted with a prescription (as of April 2026).
Read the full articles
- Cerebrolysin — full monograph: mechanism, research, dosing & references
- Dihexa — full monograph: mechanism, research, dosing & references